Federal Science and Technology Grants

The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinicians firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.

Project Title: New Seagrass Surveys of Post Construction Survey Site to Determine Recovery and Site Conditions for Environmental Natural Resource Technical Support U.S. Army Corps of Engineers, Galveston District.A cooperative agreement is being offered ONLY to members of the Cooperative Ecosystem Studies Units (CESU) Program Region(s) identified above. Award will be made upon mutual agreement and acceptance of the terms and conditions contained in the request for proposal and the of the recipients CESU Master Agreement.Note the established CESU Program indirect rate is 17.5%.Responses to this Request for Statements of Interest will be used to identify potential organizations for this project. Approximately $300,000-350,000 is expected to be available to support this project for the Base Period Task 1 and 2. Additional funding may be available to the successful recipient for optional tasks.Period of Performance. The base period of the agreement will extend 150 days from date of award. There may be up to three 12-month optional tasks based on availability of funding. Budget for optional tasks is dependent upon the progress of Task 1-2 and must be determined at time of award.Description of Anticipated Work: See attached Statement of Objectives found on the Related Documents Tab.NOTE: At this time we are only requesting that you demonstrate available qualifications and capability for performing similar or same type of work by submitting a Statement of Interest. A full proposal and budget are NOT requested at this time.Submission of Your Statement of InterestStatements of Interest are due by 12:00 P.M., Central Time, on 16 Aug 2024.Submit your Statement of Interest via e-mail attachments or direct questions to:Sandy JustmanGrants SpecialistUSACE, Fort Worth DistrictEmail: sandra.justman@usace.army.milOffice: 817-886-1073Chanley JenkinsProject ManagerUSACE, Fort Worth DistrictEmail: chanley.r.jenkins@usace.army.milOffice: 918-671-9132Review of Statements Received: All statements of interest received from a member of the CESU Region(s) identified above will be evaluated by a board comprised of one or more people at the receiving installation or activity, who will determine which statement(s) best meet the program objectives: offer the most highly qualified Principal Investigator, have the most relevant experience and the highest capability to successfully meet the program objectives. Submitters whose statements are determined to best meet the program objectives will be invited to submit a full proposal.This funding opportunity is ONLY available for Cooperative Ecosystem Study Units under the Gulf Coast South Florida Caribbean CESU Units.For the full RSOI description and submittal information click on the Related Documents Tab.

This funding opportunity seeks innovative research proposals from various entities, including businesses and universities, to develop groundbreaking technologies for national security, focusing on areas like novel materials, quantum computing, and artificial intelligence.

This program provides funding for U.S.-based researchers and institutions to develop innovative technologies and processes that enhance environmental sustainability and resilience while promoting efficient resource use.

This funding opportunity supports research aimed at improving the understanding and resilience of coastal regions facing climate change and environmental challenges, targeting eligible institutions and researchers in the U.S. and abroad.

This program provides funding for U.S.-based institutions to conduct research and mapping of the lunar surface, supporting future exploration missions to the Moon.

This competition provides funding and support for teams developing innovative high-temperature seismic sensors to improve geothermal energy monitoring and enhance the understanding of subsurface conditions.

This program provides funding to state and local government forensic laboratories to improve their DNA processing capabilities, reduce backlogs, and enhance public safety through faster criminal investigations.

The COEs are multi-disciplinary, university-based research and education Centers that conduct rigorous, innovative and useful research. DHS expects the COEs to break new theoretical and empirical ground as well as adapt existing approaches to Homeland Security missions and technology gaps. Research methods proposed under these funding continuations should be rooted in rigorous science and engineering disciplines. Knowledge generated by the COE's research must be amenable to integration with homeland security customers. As a whole, the portfolio of proposed projects should generate substantial original and cutting-edge research results. Applications for supplemental funding will be considered for research and education activities within the scope of work for each COEThis NOFO is for supplemental awards for existing Centers of Excellence (COEs) recipients:National Counterterrorism Innovation, Technology and Education (NCITE) - University of Nebraska OmahaSoft Target Engineering to Neutralize the Threat Reality (SENTRY) - Northeastern UniversityCritical Infrastructure Resilience Institute (CIRI) - University of Illinois at Urbana-ChampaignCoastal Resilience Center (CRC) - University of North Carolina at Chapel HillCenter for Criminal Investigations and Network Analysis (CINA) - George Mason UniversityCenter for Accelerating Operational Efficiency (CAOE) - Arizona State UniversityCenter for Cross-Border Threats Screening and Supply Chain Defense (CBTS) - Texas A University

This funding opportunity provides substantial financial support to the Icahn School of Medicine at Mount Sinai for managing a large-scale clinical research network focused on advancing cardiac surgical science and improving patient outcomes through multiple randomized clinical trials.

This funding opportunity supports research projects aimed at preventing and addressing hate crimes, with a focus on interventions, strategies, and evaluations in both community and school settings.

Key aspects of the TSA: Multidisciplinary Collaboration: The success of the project should depend on the unique skills and perspectives of each partner. The application must clearly define the synergistic components that will facilitate and accelerate progress in melanoma in a way that could not be accomplished through independent efforts. The plans for interactions among all PIs and institutions involved must be clearly articulated. Collectively, the members of the research team should represent the appropriate diversity of expertise necessary for addressing the proposed research question. Participating institutions must be willing to resolve potential intellectual and material property issues and remove institutional barriers to achieving high levels of cooperation. The following components of the proposed multidisciplinary collaboration are encouraged but not required: It is strongly encouraged that the research team has a least one investigator, key personnel, or consultant who can provide input on the ultimate utility/applicability (short- or long-term) of the anticipated outcome(s) to the melanoma field and/or patient care. The inclusion of an early-career investigator is encouraged. An early-career investigator is defined as an independent, early-career researcher or physician-scientist within 7 years of receiving their first faculty appointment by the time of the full application deadline. Investigators in mentored positions, (e.g., postdoctoral fellows) are not eligible to be named as a PI on a TSA application. The inclusion of a military and/or U.S. Department of Veterans Affairs (VA) investigator is encouraged. A military or VA investigator is defined as an investigator who is active-duty, active reserve, active duty detailed to agencies outside of the Department of Defense (DOD), civilian DOD investigators, or an investigator at a VA research facility. If included as PI on the research team, the military/VA investigator should have a substantial role in the research and should not be included only for access to active-duty military and/or VA populations. Impact: The application must articulate the impact the proposed work, including basic research, will have on melanoma research and/or patient care. Outcomes from this award are expected to expedite the advancement of promising ideas toward clinical applications and/or improve the current state of the science/technology in the melanoma field. The proposed research must relate to at least one of the FY24 MRP Focus Areas in Section II.A.1. Preliminary Data Required: Applications must include preliminary data to support feasibility of the study. However, these data do not necessarily need to be derived from melanoma studies. Any unpublished, preliminary data presented should originate from the laboratory of at least one of the PIs or other member(s) of the research team.

This funding opportunity provides financial support for universities and research institutions to conduct research and develop monitoring programs aimed at understanding and conserving imperiled bumble bee populations, particularly the endangered rusty patched bumble bee.

This program provides funding to a variety of organizations to create experiential learning opportunities in emerging technology fields, helping individuals from diverse backgrounds gain skills and transition into STEM careers.

This program provides funding to a consortium led by a qualified university to develop innovative safety strategies and infrastructure improvements aimed at reducing traffic fatalities in American Indian and Alaska Native communities.

demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the best and brightest in their field(s) through extraordinary creativity, vision, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and must exhibit strong potential for future leadership in breast cancer research.As the intent of the Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the individual named as the Principal Investigator (PI) in the application to go beyond conventional thinking in their field and the innovative contribution that the PI can make toward ending breast cancer. The application should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention.Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award. Individuals from other disciplines who apply novel concepts to breast cancer are encouraged to submit.The PI is encouraged to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. The PIs research team must include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be independent of their employment, and they may not be employees of any organizations participating in the application. The consumer advocates should have a high level of knowledge of current breast cancer issues and the appropriate background and/or training in breast cancer research to contribute to the project. Their role should be focused on providing objective input throughout the research effort and its potential impact for individuals with, or at risk for, breast cancer.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 BCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public. Collaborations between researchers at military or Veteran institutions and non-military institutions are strongly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the partners bring to the research effort, ultimately advancing cancer research that is of significance to the Warfighter, military Families, and the American public.Clinical trials are allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes: (1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 Era of Hope Scholar Award should not exceed $3.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $5.4M to fund approximately one Era of Hope Scholar Award application. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding opportunity provides financial support to small businesses engaged in innovative research and development projects that have the potential for commercialization and significant societal impact.

This funding opportunity provides financial support for research and evaluation projects aimed at improving forensic science practices and their impact on the criminal justice system across the United States, targeting a wide range of eligible organizations including governments, educational institutions, and nonprofits.

This grant provides funding to collaborative networks of universities and research institutions to accelerate the commercialization of scientific discoveries and deep technologies that can benefit society.

This funding opportunity supports collaborative research teams in developing sustainable polymers through advanced data analytics and artificial intelligence, aiming to foster innovation and train a skilled workforce in this field.